|
Market Closed -
Nasdaq
00:00:00 22/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 13.16 USD | +5.87% |
|
-1.42% | -24.76% |
| Market Cap | 7.7B 10.5B 8.99B 8.41B 14.46B 1,004B 14.65B 99.41B 38.77B 505B 39.42B 38.56B 1,669B | P/E 2026 * |
-10.8x | P/E 2027 * | -11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.23B 9.85B 8.44B 7.9B 13.57B 943B 13.75B 93.3B 36.38B 474B 37B 36.19B 1,566B | EV / Sales 2026 * |
2,469x | EV / Sales 2027 * | 179x |
| Free-Float |
19.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Summit Therapeutics Inc.
| 1 day | +5.87% | ||
| 1 week | -1.42% | ||
| Current month | +1.08% | ||
| 1 month | -10.72% | ||
| 3 months | -20.82% | ||
| 6 months | -17.44% | ||
| Current year | -24.76% |
| 1 week | 12.07 |  | 13.53 |
| 1 month | 12.07 | | 15.75 |
| Current year | 12.07 | | 29.23 |
| 1 year | 12.07 | | 30.05 |
| 3 years | 1.52 | | 36.91 |
| 5 years | 0.66 | | 36.91 |
| 10 years | 0.66 | | 36.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 54 | 25/07/2022 |
Robert Duggan
CEO | Chief Executive Officer | 81 | 01/04/2020 |
| Director of Finance/CFO | 48 | 02/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Duggan
CHM | Chairman | 81 | 01/02/2020 |
| Director/Board Member | 48 | 01/12/2019 | |
Mahkam Zanganeh
BRD | Director/Board Member | 54 | 11/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/01/26 | Free | Controller/Auditor | 30,000 | 0.0040% | ||
| 02/01/26 | Free | Director | 42,180 | 0.0057% | ||
| 02/01/26 | Free | Chief Executive Officer | 11,232 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.87% | -1.42% | -49.77% | +623.08% | 10.5B | |
| -3.00% | +2.27% | +73.26% | +109.90% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.82% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.86% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +480.92% | 27.47B | |
| +2.74% | +12.98% | +54.92% | +25.77% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -15.31% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| +0.94% | +3.36% | +15.30% | +548.19% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +151.77% | 13.4B | |
| Average | +1.71% | +7.38% | +48.20% | +240.22% | 30B | |
| Weighted average by Cap. | +0.92% | +9.10% | +54.25% | +174.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.93M 3.99M 3.42M 3.2M 5.49M 382M 5.57M 37.78M 14.73M 192M 14.98M 14.66M 634M | 41.79M 56.96M 48.8M 45.66M 78.44M 5.45B 79.47M 539M 210M 2.74B 214M 209M 9.06B |
| Net income | -692M -943M -808M -756M -1.3B -90.24B -1.32B -8.93B -3.48B -45.33B -3.54B -3.46B -150B | -730M -995M -852M -797M -1.37B -95.17B -1.39B -9.42B -3.67B -47.81B -3.73B -3.65B -158B |
| Net Debt | -474M -645M -553M -517M -889M -61.76B -901M -6.11B -2.38B -31.02B -2.42B -2.37B -103B | -202M -276M -236M -221M -380M -26.38B -385M -2.61B -1.02B -13.25B -1.04B -1.01B -43.83B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | $13.16 | +5.87% | 7,074,307 |
| 20/08/26 | $12.43 | -5.19% | 6,568,692 |
| 19/08/26 | $13.11 | +2.26% | 5,431,233 |
| 18/08/26 | $12.82 | +0.31% | 4,603,920 |
| 17/08/26 | $12.78 | -4.27% | 9,878,550 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SMMT Stock
Select your edition
All financial news and data tailored to specific country editions
